vitality life science retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Retatrutide: The Most Powerful Breakthrough

CrossRef Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD Xiaoxue Long, Hui Wang, Yuwei Lu, Xiaojing Gao, Yuanyuan Xiao, Mingliang Zhang, Jingyi Guo, Jingyi Yang, Ruiqi Zhang, Qian Li, Guiyun Zhou, Ruibao Yang, Feng Chen, Qingqing Wu, Liming Sun, Chengshuang Chu, Xuexue Zhu, Zhengjun Wu, Quanlu Ren, Chunping You Cell Metabolism .2025

It is a triple receptor agonist that targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously

Women with untreated progesterone deficiency may therefore experience stronger GLP-1 side effects regardless of dose

According to clinical studies, patients who took Semaglutide injections generally lost about 5% of their body weight by the three-month mark and 10% by the six-month mark

European Journal of Pharmacology, 878 ,

[14] These are real effects, but they are small compared with prescription GLP-1 drugs, which is exactly the point of the next section